CT主动脉瓣钙化评分用于评估主动脉瓣狭窄进展
研究在重复性队列(33例)和进展队列(81例)中比较CT-AVC与超声心动图追踪主动脉瓣狭窄进展的能力。CT-AVC重复性优秀(ICC 0.99),年进展中位数152 AU/年,Cohen's d=3.12,显著高于各超声指标,提示CT-AVC在评估进展方面更具优势。
要点
- CT-AVC重复性优秀(ICC 0.99),优于主动脉瓣面积(ICC 0.85)。
- CT-AVC年进展中位数152 AU/年,效应量Cohen's d=3.12。
- CT-AVC追踪狭窄进展的标准化效应量是超声指标的两倍以上。
核心结论
- CT-AVC重复性好,且经测量重复性标准化后的年进展幅度大于超声心动图指标。
研究设计与样本
- 重复性队列33例(年龄71±8岁)在4周内重复CT-AVC或超声心动图。
- 进展队列81例(年龄72±8岁)每年接受CT-AVC和/或超声心动图检查。
主要发现
- CT-AVC的扫描-重扫描重复性优秀:一致性界限-12%至10%,ICC 0.99。
- CT-AVC年进展中位数152 AU/年(65-375 AU/年)。
- 超声年变化中位数:峰值流速0.1 m/s/年,平均压差2 mm Hg/年,主动脉瓣面积-0.1 cm2/年。
- Cohen's d:CT-AVC 3.12,峰值流速0.71,平均压差0.66,主动脉瓣面积0.59,无量纲指数1.41。
关键数值与推荐
- CT-AVC扫描-重扫描一致性界限-12%至10%,ICC 0.99。
- 峰值流速一致性界限-7%至+17%,ICC 0.92;平均压差-25%至27%,ICC 0.96。
- 无量纲指数一致性界限-11%至+15%,ICC 0.98;主动脉瓣面积-44%至+28%,ICC 0.85。
临床怎么用
- CT-AVC可作为评估主动脉瓣狭窄进展的重复性良好的影像学指标。
- CT-AVC追踪进展的标准化效应量大于超声心动图指标,或有助于减少所需样本量。
局限性
- 进展队列中10例(16%)CT扫描因图像质量不合格被排除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: CT quantification of aortic valve calcification (CT-AVC) is useful in the assessment of aortic stenosis severity. Our objective was to assess its ability to track aortic stenosis progression compared with echocardiography. METHODS: Subjects were recruited in two cohorts: (1) a reproducibility cohort where patients underwent repeat CT-AVC or echocardiography within 4 weeks and (2) a disease progression cohort where patients underwent annual CT-AVC and/or echocardiography. Cohen's d-statistic (d) was computed from the ratio of annualised progression and measurement repeatability and used to estimate group sizes required to detect annualised changes in CT-AVC and echocardiography. RESULTS: A total of 33 (age 71±8) and 81 participants (age 72±8) were recruited to the reproducibility and progression cohorts, respectively. Ten CT scans (16%) were excluded from the progression cohort due to non-diagnostic image quality. Scan-rescan reproducibility was excellent for CT-AVC (limits of agreement -12% to 10 %, intraclass correlation (ICC) 0.99), peak velocity (-7% to +17%; ICC 0.92) mean gradient (-25% to 27%, ICC 0.96) and dimensionless index (-11% to +15%; ICC 0.98). Repeat measurements of aortic valve area (AVA) were less reliable (-44% to +28%, ICC 0.85).CT-AVC progressed by 152 (65-375) AU/year. For echocardiography, the median annual change in peak velocity was 0.1 (0.0-0.3) m/s/year, mean gradient 2 (0-4) mm Hg/year and AVA -0.1 (-0.2-0.0) cm2/year. Cohen's d-statistic was more than double for CT-AVC (d=3.12) than each echocardiographic measure (peak velocity d=0.71 ; mean gradient d=0.66; AVA d=0.59, dimensionless index d=1.41). CONCLUSION: CT-AVC is reproducible and demonstrates larger increases over time normalised to measurement repeatability compared with echocardiographic measures.
引用
- Doris MK, Jenkins W, Robson P, et al. Computed tomography aortic valve calcium scoring for the assessment of aortic stenosis progression. Heart. 2020. PMID: 33020228. doi:10.1136/heartjnl-2020-317125
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。